MCPMercoPress·1hHealth
score+0.70
A personalized mRNA therapy passes a phase 3 melanoma trial for the first time
Original
A personalized mRNA therapy passes a phase 3 melanoma trial for the first time
“Highlights a historic clinical milestone for cancer treatment, framing scientific progress as a significant breakthrough.”